We explored how the probiotic mixture ENDOLAC, containing Lactobacillus acidophilus, influences asthma-related allergic inflammation. In a study with 14 participants suffering from asthma and other allergic conditions, we measured the levels of circulating CD34+ Hemopoietic Precursors (HPC) before and after 30 days of treatment.
After taking the probiotic daily, participants showed a significant decrease in CD34+ cell counts, indicating that Lactobacillus acidophilus may help improve allergic responses. These findings suggest that integrating this probiotic into standard treatments could enhance their effectiveness for allergy management.
Read More
We aimed to explore the potential benefits of a novel herbal medicine, MA, and its fermented version, MA128, on asthma treatment. This involved inducing asthma in mice and administering these treatments regularly for four weeks.
Our findings revealed that both MA and MA128 successfully reduced inflammation and airway hyperresponsiveness. Notably, the fermentation process with Lactobacillus acidophilus enhanced the effectiveness of the herbal remedy, influencing immune responses positively.
This indicates a promising avenue for asthma management through natural products, though further research is needed for clear clinical applications.
Read More
We examined how fermenting Ixeris dentata with lactic acid bacteria like Lactobacillus acidophilus influences allergic reactions. In our findings, these fermented extracts significantly reduced reactions in mice, such as itching and passive cutaneous anaphylaxis, more effectively than non-fermented versions. The fermentation process appeared to enhance the anti-allergic properties, suggesting a potential remedy for conditions like asthma and rhinitis. However, while the results are promising, we saw that the benefits may vary and further research is needed to fully understand the impact on human asthma.
Read More